Mohammad Abdur Rashid, MSc, MPhil, PhD

The State University of New Jersey

United States

An experienced researcher and educator with 23 years of experience in biomedical research and education. Expert in molecular biology, biochemistry, pharmacology, regenerative neurobiology, and cancer-related neurotoxic effects driven cognitive dysfunction (chemobrain) and develop effective and safe therapies to prevent this neurotoxicity in mouse models and in vitro models using human excitatory cortical neurons, sensory neurons, and spinal cord neurons derived from human induced pluripotent stem cells (iPSCs) as well as embryonic stem cells. Experienced in managing and supervising a large research group in molecular biology, regenerative neurobiology, and chemobrain research. Authored and co-authored 42+ research articles, 2 book chapters, and 40+ peer-reviewed abstracts and has an H-Index of 15. Awarded the Director award at the National Institute of Health (National Center for Advancing Translational Science) presented the research paper, and Best Research Outstanding Poster Award as a Young Scientist, Inaugural Symposium on US-Korea Collaborative Biomedical Research, NIH, Bethesda, Maryland, USA. Has 1 US patent on Istradefylline (KW-6002) as a therapeutic treatment for chemobrain. Regular ad-hoc reviewer of journals including the International Journal of Neuroscience, Journal of Diabetes & Vascular Disease Research, International Journal of Nutrition, Pharmacology, Neurological Diseases (Int J Nutr Pharmacol Neurol Dis), International Journal of Food and Nutrition, Science Document, BMC Neuroscience, and Stem Cells International.

Reseadrivesrea: I am focusing on research to understand the underlying neuropathological mechanisms that drive chemotherapy-induced cognitive impairment (CICI, also known as chemobrain), which resembles the brain aging process. I am also studying the mechanisms of human neurodegenerative diseases, particularly AD and PD using the transgenic mouse model.